Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemiaViktoras Frismantas, Jean‐Pierre Bourquin, Maria Pamela Dobay et al.|Blood|2017Cited by 263
Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic optionsUte Fischer, Martin Schrappe, Michael Förster et al.|Nature Genetics|2015Cited by 258
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALLScott McComb, Beat Bornhäuser, Júlia Aguadé-Gorgorió et al.|Science Translational Medicine|2016Cited by 119
The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 VulnerabilityYun Huang, Jean‐Pierre Bourquin, Brice Mouttet et al.|Cancer Cell|2019Cited by 63
PDX models recapitulate the genetic and epigenetic landscape of pediatric T‐cell leukemiaPaulina Richter‐Pechańska, Andreas E. Kulozik, Joachim B. Kunz et al.|EMBO Molecular Medicine|2018Cited by 53